Headline
The latest stories from AHA Today.
During the COVID-19 pandemic, Milwaukee-based Advocate Aurora Health used its broad resources to ensure adequate supplies and equipment, develop a flexible staffing strategy, create surge predictive models and increase operational efficiencies.
The Senate Finance Committee held a hearing to examine how to improve access to mental health and substance use disorder treatment and address inequities.
More than 1 million Americans selecting a 2021 health plan through the federally facilitated marketplace since April 1 will pay $10 or less per month, the Centers for Medicare & Medicaid Services announced.
The Health Resources and Services Administration awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in vulnerable and medically underserved communities.
The Food and Drug Administration added sodium citrate tubes used to collect blood specimens to its device shortage list and recommended health care providers only use the tubes when medically necessary, among other conservation strategies.
The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
Novavax announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.4% overall efficacy.
The Health Care Payment Learning and Action Network has created an advisory team to help identify and prioritize opportunities to advance health equity through alternative payment models and inform its priorities and initiatives.
The Centers for Disease Control and Prevention alerted clinicians to an increase in Respiratory Syncytial Virus since late March in certain Southern states.
A study comparing suspected emergency department visits for adolescent suicide attempts between February and March of this year to the same period in 2019 showed an increase of 50.6% among girls aged 12-17 years and 3.7% for boys in the same age range, the Centers for Disease Control and Prevention…